Galychpharm PJSC (UKEX:GFARM) ROC %: 0.00% (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

UKEX:GFARM Galychpharm PJSC UKEX:GFARM
14 GF Score
Price ₴100.00
! 1 Warning Sign
View Full Analysis

What is Galychpharm PJSC ROC %?

Galychpharm PJSC UKEX:GFARM 14 ROC % is 0.00% as of . 20. GuruFocus rates UKEX:GFARM with a GF Score™ of 14/100. The stock has 1 warning sign investors should review.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Galychpharm PJSC's annualized return on capital (ROC %) for the quarter that ended in . 20 was 0.00%.

As of today (2026-07-15), Galychpharm PJSC's WACC % is 0.00%. Galychpharm PJSC's ROC % is 0.00% (calculated using TTM income statement data). Galychpharm PJSC earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Galychpharm PJSC  (UKEX:GFARM) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Galychpharm PJSC's WACC % is 0.00%. Galychpharm PJSC's ROC % is 0.00% (calculated using TTM income statement data). Galychpharm PJSC earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Galychpharm PJSC ROC % Related Terms

Galychpharm PJSC ROC % Historical Data

* Premium members only.

The historical data trend for Galychpharm PJSC's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Galychpharm PJSC ROC % Chart

Galychpharm PJSC Annual Data
Trend
ROC %

Galychpharm PJSC Semi-Annual Data
ROC %
UKEX:GFARM
14GF Score
Galychpharm PJSC UKEX:GFARM
ROC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Galychpharm PJSC ROC % Calculation

Galychpharm PJSC's annualized Return on Capital (ROC %) for the fiscal year that ended in . 20 is calculated as:

ROC % (A: . 20 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: . 20 ) + Invested Capital (A: . 20 ))/ count )
= * ( 1 - % )/( ( + )/ )
=/
= %

where

Invested Capital(A: . 20 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
= - - ( - max(0, - +))
=

Invested Capital(A: . 20 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
= - - ( - max(0, - +))
=

Galychpharm PJSC's annualized Return on Capital (ROC %) for the quarter that ended in . 20 is calculated as:

ROC % (Q: . 20 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: . 20 ) + Invested Capital (Q: . 20 ))/ count )
= * ( 1 - % )/( ( + )/ )
=/
= %

where

Invested Capital(Q: . 20 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
= - - ( - max(0, - +))
=

Invested Capital(Q: . 20 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
= - - ( - max(0, - +))
=

Note: The Operating Income data used here is one times the annual (. 20) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROC % →
What does a ROC % of 0.00% mean?
Galychpharm PJSC (UKEX:GFARM) has a ROC % of 0.00% as of . 20. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Galychpharm PJSC and its competitors.
Is Galychpharm PJSC's ROC % too high?
Galychpharm PJSC's current ROC % is 0.00%. Overall, Galychpharm PJSC has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Galychpharm PJSC's ROC % compare to HSTC and STLT?
Galychpharm PJSC's ROC % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median ROC % is 4.49. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Drug Manufacturers company?
The median ROC % among Drug Manufacturers companies is 4.49, based on 990 companies in the industry. Companies in the top quartile (top 25%) have a ROC % significantly above this median, while those in the bottom quartile fall well below. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Galychpharm PJSC and its competitors. For the Drug Manufacturers industry, the median ROC % is 4.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Galychpharm PJSC's current ROC % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galychpharm PJSC stock overvalued right now?
Galychpharm PJSC (UKEX:GFARM) has a current ROC % of 0.00%. The current ROC % is 0.00%. Galychpharm PJSC's overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For Galychpharm PJSC (UKEX:GFARM), the current ROC % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Galychpharm PJSC Business Description

Address 6/8 Opryshkivska Street, Lviv, UKR, 79024
Galychpharm PJSC is engaged in the production and sale of drugs and other medicines. It offers phytochemical substances, crude drugs, injection ampoules, tablets, solutions, extracts, and syrups.
14GF Score

Get the complete analysis for UKEX:GFARM

ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₴100.00
Price